Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Mid-range Performer

1932.5000 -71.90 (-3.59%)

NSE Nov 07, 2025 15:31 PM

26.83% Fall from 52W High

Volume: 156.8K

High volume today

Caplin Point Laboratories Ltd.

14 May 2025

1932.50

-3.59%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release regarding receipt of USFDA Approval is attached herewith.

More from Caplin Point Laboratories Ltd.

Recommended

Five Interesting Stocks Today - November 7, 2025

The Baseline | 07 Nov 2025, 04:49PM

Market closes lower, NHPC's Q2 net profit grows 12% YoY

Trendlyne Marketwatch | 07 Nov 2025, 04:12PM

Caplin Point Laboratories maintains export momentum, expands ambitions to new markets